Algo version: 0.98b
CYCCP is listed at the NASDAQ Exchange
CYCCP [CYCCP]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is CYCCP stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Cyclacel Pharmaceuticals pays dividends. Last time was Thursday 1st of February 2024 where the investors holding the stock on Friday 19th of January 2024 were paid $0.15000 per share. Over the last 59 times between 2006 and 2024, Cyclacel Pharmaceuticals has paid $4.8625 with an average of $0.08 per share.

Sorry, we do not have any analyst data for this ticker

On Friday 21st of November 2014, Cyclacel Pharmaceuticals had a stock price of $7.51. If you invested back then, your return now would be a loss of $-0.570 per share or -7.59%

No, the average daily trading liquidity for Cyclacel Pharmaceuticals is $12 046 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Cyclacel Pharmaceuticals has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Cyclacel Pharmaceuticals to be medium [0.7 out of 1]